MusthInsider

Latest On ADMA Biologics, Inc (ADMA):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-11 01:31 EST	News	ADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59M	N/A
2023-05-11 01:30 EST	News	ADMA Biologics, Inc. (ADMA) Q1 2023 Earnings Call Transcript	N/A
2023-05-09 23:31 EST	News	ADMA Biologics Q1 2023 Earnings Preview	N/A
2023-03-30 00:16 EST	News	ADMA Biologics: Growth Trends Pointing To Profitability	N/A
2023-03-24 06:16 EST	News	ADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88M	N/A
2023-03-24 06:16 EST	News	ADMA Biologics expects first-time positive EBITDA by second half of year	N/A
2023-03-24 06:15 EST	News	ADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Call Transcript	N/A
2023-03-22 23:00 EST	News	ADMA Biologics Q4 2022 Earnings Preview	N/A
2023-02-08 18:02 EST	News	ADMA Biocenters receives FDA approval for eighth plasma collection center	N/A
2023-01-17 17:02 EST	News	ADMA Biologics gains as guidance exceeds consensus	N/A
2023-01-15 06:00 EST	News	ADMA Biologics: FY22 Numbers Key Inflection Point	N/A
2022-12-13 19:01 EST	News	Adma gets FDA approval for room temperature storage of Asceniv, Bivigam	N/A
2022-12-08 03:17 EST	News	ADMA Biologics stock dips after pricing ~$60M share offering	N/A
2022-12-07 07:16 EST	News	ADMA Biologics down 7% following stock offering	N/A
2022-11-11 05:31 EST	News	ADMA Biologics hits 52-week high after strong Q3 beat	N/A
2022-11-09 19:31 EST	News	ADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61M	N/A
2022-11-09 19:30 EST	News	ADMA Biologics, Inc. (ADMA) Q3 2022 Earnings Call Transcript	N/A
2022-11-09 01:31 EST	News	ADMA Biologics Q3 2022 Earnings Preview	N/A
2022-10-31 13:46 EST	News	Adma stock rises on FDA approval of North Carolina-based plasma collection center	N/A
2022-10-24 18:01 EST	News	Adma Biologics: Understanding The Risks Of Blood Plasma Collection	N/A
2022-08-22 16:50 EST	News	ADMA Biologics: Strong Growth Is Clearing The Path To Profitability	N/A
2022-08-11 22:17 EST	News	ADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-11 22:16 EST	News	Adma stock rises 10% after Q2 revenue nearly doubles, net loss narrows	N/A
2022-08-11 05:31 EST	News	ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M	N/A
2022-08-11 05:30 EST	News	ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-09 17:45 EST	News	ADMA Biologics Q2 2022 Earnings Preview	N/A
2022-06-27 23:02 EST	News	ADMA's 6th plasma collection facility gets FDA approval	N/A
2022-06-21 22:02 EST	News	ADMA biologics to enter Russell 2000 index	N/A
2022-05-13 06:31 EST	News	ADMA Biologics: A Path To Profits Looks Clear	N/A
2022-05-12 11:47 EST	News	ADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call Transcript	N/A
2022-05-11 18:00 EST	News	ADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95M	N/A
2022-05-11 18:00 EST	News	ADMA Biologics up 4% after increasing 2022 revenue guidance	N/A
2022-05-10 22:45 EST	News	ADMA Biologics Q1 2022 Earnings Preview	N/A
2022-04-19 02:16 EST	News	ADMA: Pertinent Updates	N/A
2022-04-04 13:21 EST	News	ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2021 Results - Earnings Call Transcript	N/A
2022-03-29 21:17 EST	News	ADMA Biologics' 2021 Numbers Showed Continued Strong Execution	N/A
2022-03-25 12:19 EST	News	ADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61M	N/A
2022-03-25 12:19 EST	News	ADMA Biologics up in after-hours trading following quarterly top and bottom line beats	N/A
2022-03-25 12:18 EST	News	ADMA Biologics gets FDA approval to extend shelf life of Asceniv, Bivigam	N/A
2022-03-24 02:33 EST	News	ADMA Biologics Q4 2021 Earnings Preview	N/A
2022-02-10 22:16 EST	News	Adma Biologics activist said to support strategic review	N/A
2022-01-19 08:15 EST	News	ADMA biologics expects record preliminary 4Q and FY21 revenues to be above the consensus	N/A
2022-01-18 16:46 EST	News	ADMA Biologics wins FDA nod for its fourth plasma collection center	N/A
2022-01-18 16:46 EST	News	ADMA Biologics: 2021 Was Tough	N/A
2021-12-28 22:16 EST	News	FDA updates EUA for COVID convalescent plasma limiting use to certain patients	N/A
2021-12-09 15:17 EST	News	ADMA Biologics secures new European patent related to S. pneumonia infections	N/A
2021-11-20 23:16 EST	News	ADMA Biologics: Turning A Corner	N/A
2021-11-11 20:31 EST	News	ADMA Biologics raised to Strong Buy at Raymond James citing financial momentum	N/A
2021-11-11 00:15 EST	News	ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call Transcript	N/A
2021-11-10 01:31 EST	News	ADMA Biologics Q3 2021 Earnings Preview	N/A

About ADMA Biologics, Inc (ADMA):

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

See Advanced Chart

General

Name ADMA Biologics, Inc
Symbol ADMA
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 313
Fiscal Year EndDecember
IPO Date2013-10-17
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.admabiologics.com

Valuation

Price/Sales (Trailing 12 Mt.) 5.32
Price/Book (Most Recent Quarter) 3.7
Enterprise Value Revenue 7.55

Financials

Most Recent Quarter 2020-09-30
Next Quarter EPS Estimate -$0.17
Profit Margin -166%
Operating Margin -138%
Return on Assets -21%
Return on Equity -124%
Revenue 40.3 million
Earnings Per Share -$1.24
Revenue Per Share $0.53
Gross Profit -10155155
Quarterly Earnings Growth 42.3%

Highlights

Market Capitalization 195.71 million
EBITDA -52103768
Analyst Target Price $8.83
Book Value Per Share $0.80

Share Statistics

Shares Outstanding 94.55 million
Shares Float 76.07 million
% Held by Insiders 213%
% Held by Institutions 54.51%
Shares Short 8.18 million
Shares Short Prior Month 8.75 million
Short Ratio 1.91
Short % of Float 12%
Short % of Shares Outstanding 9%

Technicals

Beta 1.7
52 Week High $4.2
52 Week Low $1.73
50 Day Moving Average 2.42
200 Day Moving Average 2.23

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

ADMA Biologics, Inc (ADMA) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

ADMA Biologics, Inc (ADMA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-09-30	2020-11-05	$N/A	-$0.19	-$0.20	4.04%
2020-06-30	2020-08-05	$N/A	-$0.23	-$0.16	-42.24%
2020-03-31	2020-05-06	$N/A	-$0.26	-$0.11	-128.07%
2019-12-31	2020-03-12	$12.04 million	-$0.18	-$0.18	-0.95%
2019-09-30	2019-11-06	$7.22 million	-$0.19	-$0.23	15.56%
2019-06-30	2019-08-08	$6.56 million	-$0.25	-$0.29	14.65%
2019-03-31	2019-05-08	$3.53 million	-$0.28	-$0.32	11.39%
2018-12-31	2019-03-13	$4.06 million	-$0.39	-$0.33	-17.15%
2018-09-30	2018-11-08	$4.23 million	-$0.33	-$0.31	-6.45%
2018-06-30	2018-08-10	$4.66 million	-$0.35	-$0.31	-11.86%
2018-03-31	2018-05-14	$4.04 million	-$0.39	-$0.31	-26.83%
2017-12-31	2018-03-05	$12 million	-$0.24	-$0.39	38.46%
2017-09-30	2017-11-03	$4.73 million	-$0.59	-$0.50	-18.59%
2017-06-30	2017-08-11	$3.4 million	-$0.55	-$0.30	-84.87%
2017-03-31	2017-05-12	$2.63 million	-$0.51	-$0.28	-80.53%
2016-12-31	2017-02-24	$3.33 million	-$0.34	-$0.32	-5.59%
2016-09-30	2016-11-10	$2.94 million	-$0.34	-$0.41	17.87%
2016-06-30	2016-08-12	$2.27 million	-$0.50	-$0.38	-30.89%
2016-03-31	2016-05-13	$2.12 million	-$0.43	-$0.44	2.82%
2015-12-31	2016-03-23	$2.51 million	-$0.44	-$0.45	2.22%
2015-09-30	2015-11-10	$1.85 million	-$0.48	-$0.39	-23.08%
2015-06-30	2015-08-11	$1.31 million	-$0.44	-$0.35	-25.71%
2015-03-31	2015-05-12	$1.5 million	-$0.37	-$0.38	2.63%
2014-12-31	2015-03-09	$1.49 million	-$0.38	-$0.38	0%
2014-09-30	2014-11-10	$1.37 million	-$0.36	-$0.37	2.7%
2014-06-30	2014-08-11	$1.5 million	-$0.43	-$0.52	17.31%
2014-03-31	2014-05-12	$1.56 million	-$0.64	-$0.49	-30.61%
2013-12-31	2014-03-28	$425000	-$0.54	-$0.47	-14.89%
2013-09-30	2013-11-12	$1.11 million	-$0.29

ADMA Biologics, Inc (ADMA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ADMA Biologics, Inc (ADMA) Chart:

ADMA Biologics, Inc (ADMA) News:

Below you will find a list of latest news for ADMA Biologics, Inc (ADMA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ADMA Biologics, Inc (ADMA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2026-03-20	5	0	CALL	0	1	444.34	TRUE	0	0
2026-03-20	9	8.13	CALL	0	8	258.35	TRUE	0	0
2026-03-20	10	5.67	CALL	0	14	0	TRUE	0	0
2026-03-20	11	4.9	CALL	0	21	0	TRUE	0	0
2026-03-20	12	4.1	CALL	0	81	0	TRUE	0	0
2026-03-20	13	3.7	CALL	0	10	0	TRUE	0	0
2026-03-20	14	2.2	CALL	0	308	66.37	TRUE	0	0
2026-03-20	15	0.45	CALL	45	174	47.36	TRUE	-0.1	-0.18
2026-03-20	16	0.15	CALL	60	432	56.66	FALSE	-0.25	-0.63
2026-03-20	17	0.22	CALL	0	510	88.78	FALSE	0	0
2026-03-20	18	0.16	CALL	0	317	146.06	FALSE	0	0
2026-03-20	19	0.09	CALL	2	585	122.62	FALSE	-0.04	-0.31
2026-03-20	20	0.03	CALL	20	3399	115.09	FALSE	0.03	0
2026-03-20	21	0.17	CALL	0	315	229.06	FALSE	0	0
2026-03-20	22	0.07	CALL	0	435	469.01	FALSE	0	0
2026-03-20	23	0.25	CALL	0	126	546.29	FALSE	0	0
2026-03-20	24	0.3	CALL	0	415	248.18	FALSE	0	0
2026-03-20	25	0.1	CALL	0	1027	454.98	FALSE	0	0
2026-03-20	26	0	CALL	0	0	594.96	FALSE	0	0
2026-03-20	27	0.48	CALL	0	9	578.61	FALSE	0	0
2026-03-20	30	0.16	CALL	0	11	386.92	FALSE	0	0
2026-03-20	35	0.5	CALL	0	1	744.52	FALSE	0	0
2026-03-20	5	0	PUT	0	0	1434.11	FALSE	0	0
2026-03-20	9	0	PUT	0	0	570.61	FALSE	0	0
2026-03-20	10	0.16	PUT	0	1	490.95	FALSE	0	0
2026-03-20	11	0	PUT	0	0	418.47	FALSE	0	0
2026-03-20	12	0.1	PUT	0	219	351.12	FALSE	0	0
2026-03-20	13	0.15	PUT	0	2218	99.66	FALSE	0	0
2026-03-20	14	0.18	PUT	4	2250	78.65	FALSE	0.18	0
2026-03-20	15	0.44	PUT	6	1649	66.85	FALSE	0.19	0.76
2026-03-20	16	1.2	PUT	0	621	53.81	TRUE	0	0
2026-03-20	17	2.25	PUT	20	226	133	TRUE	0.23	0.11
2026-03-20	18	2.96	PUT	8	22	108.13	TRUE	0.47	0.19
2026-03-20	19	3.24	PUT	0	2	98.83	TRUE	0	0
2026-03-20	20	4.3	PUT	0	2	0	TRUE	0	0
2026-03-20	21	4.5	PUT	0	2	168.06	TRUE	0	0
2026-03-20	22	0	PUT	0	0	0	TRUE	0	0
2026-03-20	23	0	PUT	0	0	0	TRUE	0	0
2026-03-20	24	0	PUT	0	0	0	TRUE	0	0
2026-03-20	25	0	PUT	0	0	0	TRUE	0	0
2026-03-20	26	0	PUT	0	0	0	TRUE	0	0
2026-03-20	27	0	PUT	0	0	0	TRUE	0	0
2026-03-20	30	0	PUT	0	0	0	TRUE	0	0
2026-03-20	35	0	PUT	0	0	0	TRUE	0	0
2026-04-17	5	11.98	CALL	0	8	206.6	TRUE	0	0
2026-04-17	8	0	CALL	0	0	0	TRUE	0	0
2026-04-17	9	8.06	CALL	0	0	155.41	TRUE	0	0
2026-04-17	10	6	CALL	0	13	0	TRUE	0	0
2026-04-17	11	4.2	CALL	2	0	49.78	TRUE	4.2	0
2026-04-17	12	3.3	CALL	4	7	59.19	TRUE	-0.5	-0.13
2026-04-17	13	2.9	CALL	0	14	48.53	TRUE	0	0
2026-04-17	14	1.93	CALL	0	62	62.11	TRUE	0	0
2026-04-17	15	1.33	CALL	219	55	67.04	TRUE	0.18	0.16
2026-04-17	16	0.81	CALL	6468	247	61.61	FALSE	0.06	0.08
2026-04-17	17	0.45	CALL	1006	59	57.77	FALSE	-0.2	-0.31
2026-04-17	18	0.25	CALL	6290	160	56.84	FALSE	0.25	0
2026-04-17	19	0.3	CALL	0	125	55.4	FALSE	0	0
2026-04-17	20	0.05	CALL	0	105	90.27	FALSE	0	0
2026-04-17	21	0.25	CALL	0	92	125.45	FALSE	0	0
2026-04-17	22	0.1	CALL	10	126	76.1	FALSE	0.1	0
2026-04-17	23	0.02	CALL	0	30	167.26	FALSE	0	0
2026-04-17	24	0.31	CALL	0	66	179.16	FALSE	0	0
2026-04-17	25	1.15	CALL	0	32	190.55	FALSE	0	0
2026-04-17	27	0.34	CALL	0	1	174.32	FALSE	0	0
2026-04-17	30	0.32	CALL	0	1	221.9	FALSE	0	0
2026-04-17	35	0.05	CALL	0	1	303.36	FALSE	0	0
2026-04-17	5	0	PUT	0	0	436.83	FALSE	0	0
2026-04-17	8	0	PUT	0	0	278.13	FALSE	0	0
2026-04-17	9	0	PUT	0	0	240.53	FALSE	0	0
2026-04-17	10	0.5	PUT	0	1000	170.72	FALSE	0	0
2026-04-17	11	0.37	PUT	0	34	143.89	FALSE	0	0
2026-04-17	12	0.26	PUT	0	519	118.83	FALSE	0	0
2026-04-17	13	0.49	PUT	0	1612	87.94	FALSE	0	0
2026-04-17	14	0.65	PUT	25	416	65.02	FALSE	-0.03	-0.04
2026-04-17	15	1.04	PUT	18	134	62.03	FALSE	0.09	0.09
2026-04-17	16	1.59	PUT	2	78	60.51	TRUE	0.17	0.12
2026-04-17	17	2.57	PUT	20	74	77.03	TRUE	0.21	0.09
2026-04-17	18	2.64	PUT	0	27	54.56	TRUE	0	0
2026-04-17	19	3.93	PUT	0	11	79.89	TRUE	0	0
2026-04-17	20	2.5	PUT	0	16	72.54	TRUE	0	0
2026-04-17	21	0	PUT	0	0	0	TRUE	0	0
2026-04-17	22	0	PUT	0	0	0	TRUE	0	0
2026-04-17	23	4.2	PUT	0	1	0	TRUE	0	0
2026-04-17	24	0	PUT	0	0	0	TRUE	0	0
2026-04-17	25	6.6	PUT	0	5	0	TRUE	0	0
2026-04-17	27	0	PUT	0	0	0	TRUE	0	0
2026-04-17	30	0	PUT	0	0	0	TRUE	0	0
2026-04-17	35	0	PUT	0	0	0	TRUE	0	0
2026-05-15	5	0	CALL	0	0	120.64	TRUE	0	0
2026-05-15	8	0	CALL	0	0	85.08	TRUE	0	0
2026-05-15	9	0	CALL	0	0	0	TRUE	0	0
2026-05-15	10	5.18	CALL	0	76	55.72	TRUE	0	0
2026-05-15	11	5	CALL	0	2	73.73	TRUE	0	0
2026-05-15	12	0	CALL	0	0	78.38	TRUE	0	0
2026-05-15	13	4.02	CALL	0	12	61.48	TRUE	0	0
2026-05-15	14	0	CALL	0	0	59.64	TRUE	0	0
2026-05-15	15	1.93	CALL	0	37	69.02	TRUE	0	0
2026-05-15	16	1.52	CALL	0	144	68.76	FALSE	0	0
2026-05-15	17	1.17	CALL	2	44	73.1	FALSE	0.17	0.17
2026-05-15	18	0.72	CALL	21	182	65.15	FALSE	0.72	0
2026-05-15	19	0.65	CALL	0	796	65.18	FALSE	0	0
2026-05-15	20	0.5	CALL	0	2629	78.5	FALSE	0	0
2026-05-15	21	0.7	CALL	0	23	79.35	FALSE	0	0
2026-05-15	22	0.66	CALL	0	54	167.73	FALSE	0	0
2026-05-15	23	0.15	CALL	0	17	125.74	FALSE	0	0
2026-05-15	24	1.65	CALL	0	35	132.24	FALSE	0	0
2026-05-15	25	0.04	CALL	0	20	147.64	FALSE	0	0
2026-05-15	30	0.65	CALL	0	2	163.93	FALSE	0	0
2026-05-15	35	0.21	CALL	0	2	176.06	FALSE	0	0
2026-05-15	5	0	PUT	0	0	324.17	FALSE	0	0
2026-05-15	8	0	PUT	0	0	194.31	FALSE	0	0
2026-05-15	9	0	PUT	0	0	167.77	FALSE	0	0
2026-05-15	10	0	PUT	0	0	153.95	FALSE	0	0
2026-05-15	11	0.15	PUT	0	44	107.1	FALSE	0	0
2026-05-15	12	0.5	PUT	416	1179	73.74	FALSE	-0.05	-0.09
2026-05-15	13	0.68	PUT	10	1633	67.25	FALSE	0.68	0
2026-05-15	14	1.14	PUT	1	300	70.73	FALSE	0.04	0.04
2026-05-15	15	1.65	PUT	19	280	71.61	FALSE	0.17	0.11
2026-05-15	16	2.03	PUT	0	188	57.34	TRUE	0	0
2026-05-15	17	2.5	PUT	0	65	67.9	TRUE	0	0
2026-05-15	18	3.28	PUT	0	21	80.51	TRUE	0	0
2026-05-15	19	3.96	PUT	0	21	66.18	TRUE	0	0
2026-05-15	20	3.2	PUT	0	7	66.03	TRUE	0	0
2026-05-15	21	3.7	PUT	0	1	66.58	TRUE	0	0
2026-05-15	22	4.2	PUT	0	2	64.43	TRUE	0	0
2026-05-15	23	5	PUT	0	1	70.07	TRUE	0	0
2026-05-15	24	0	PUT	0	0	0	TRUE	0	0
2026-05-15	25	0	PUT	0	0	0	TRUE	0	0
2026-05-15	30	0	PUT	0	0	0	TRUE	0	0
2026-05-15	35	0	PUT	0	0	0	TRUE	0	0
2026-06-18	5	12.03	CALL	0	15	0	TRUE	0	0
2026-06-18	9	8.19	CALL	0	79	88.76	TRUE	0	0
2026-06-18	10	0	CALL	0	0	65.85	TRUE	0	0
2026-06-18	11	4.88	CALL	0	10	67.04	TRUE	0	0
2026-06-18	12	6.7	CALL	0	12	66.44	TRUE	0	0
2026-06-18	13	3.96	CALL	0	27	67.72	TRUE	0	0
2026-06-18	14	3.5	CALL	0	9	63.95	TRUE	0	0
2026-06-18	15	3	CALL	0	96	73.73	TRUE	0	0
2026-06-18	16	2.7	CALL	0	112	82.89	FALSE	0	0
2026-06-18	17	1.99	CALL	0	7	85.15	FALSE	0	0
2026-06-18	18	0.94	CALL	0	1241	65.13	FALSE	0	0
2026-06-18	19	0.71	CALL	5	46	59.17	FALSE	-0.09	-0.11
2026-06-18	20	0.58	CALL	1	665	60.82	FALSE	0.58	0
2026-06-18	22	0.25	CALL	2	234	55.76	FALSE	0.25	0
2026-06-18	25	0.8	CALL	0	25	65.07	FALSE	0	0
2026-06-18	27	0.7	CALL	0	409	67.94	FALSE	0	0
2026-06-18	30	0.37	CALL	0	15	123.1	FALSE	0	0
2026-06-18	35	0.1	CALL	0	30	163.4	FALSE	0	0
2026-06-18	5	0	PUT	0	0	261.16	FALSE	0	0
2026-06-18	9	0.46	PUT	0	8	144.2	FALSE	0	0
2026-06-18	10	0	PUT	0	0	102.53	FALSE	0	0
2026-06-18	11	0.45	PUT	10	20	70.28	FALSE	0.45	0
2026-06-18	12	0.7	PUT	0	116	57.18	FALSE	0	0
2026-06-18	13	0.89	PUT	0	121	58.49	FALSE	0	0
2026-06-18	14	1.3	PUT	0	69	72.86	FALSE	0	0
2026-06-18	15	1.68	PUT	0	189	64.07	FALSE	0	0
2026-06-18	16	3.1	PUT	0	270	57.46	TRUE	0	0
2026-06-18	17	2.7	PUT	0	35	55.58	TRUE	0	0
2026-06-18	18	3.5	PUT	0	24	61.54	TRUE	0	0
2026-06-18	19	2.65	PUT	0	10	62.41	TRUE	0	0
2026-06-18	20	5.5	PUT	0	34	59.3	TRUE	0	0
2026-06-18	22	0	PUT	0	0	41.55	TRUE	0	0
2026-06-18	25	9	PUT	0	0	0	TRUE	0	0
2026-06-18	27	0	PUT	0	0	0	TRUE	0	0
2026-06-18	30	0	PUT	0	0	0	TRUE	0	0
2026-06-18	35	0	PUT	0	0	0	TRUE	0	0
2026-08-21	10	0	CALL	0	0	75.34	TRUE	0	0
2026-08-21	11	6.6	CALL	0	3	49.18	TRUE	0	0
2026-08-21	12	0	CALL	0	0	64.68	TRUE	0	0
2026-08-21	13	4.84	CALL	0	2	61.6	TRUE	0	0
2026-08-21	14	0	CALL	0	0	63.35	TRUE	0	0
2026-08-21	15	3.1	CALL	0	101	66.36	TRUE	0	0
2026-08-21	16	2.6	CALL	0	15	68.9	FALSE	0	0
2026-08-21	17	2.13	CALL	0	255	58.19	FALSE	0	0
2026-08-21	18	1.6	CALL	5	58	62.53	FALSE	1.6	0
2026-08-21	19	2.12	CALL	0	7	48.44	FALSE	0	0
2026-08-21	20	1	CALL	1	196	58.9	FALSE	1	0
2026-08-21	21	0.9	CALL	0	19	55.82	FALSE	0	0
2026-08-21	22	0.75	CALL	0	20	70.09	FALSE	0	0
2026-08-21	23	0.95	CALL	0	1	68.39	FALSE	0	0
2026-08-21	24	0.85	CALL	0	2	76.95	FALSE	0	0
2026-08-21	25	0.94	CALL	0	9	72.7	FALSE	0	0
2026-08-21	26	0	CALL	0	0	58.2	FALSE	0	0
2026-08-21	27	0.12	CALL	3	6	49.9	FALSE	0.12	0
2026-08-21	30	0.5	CALL	0	6	76.05	FALSE	0	0
2026-08-21	10	0.47	PUT	0	98	82.37	FALSE	0	0
2026-08-21	11	0.6	PUT	0	205	75.6	FALSE	0	0
2026-08-21	12	1	PUT	0	11	61.58	FALSE	0	0
2026-08-21	13	1.35	PUT	0	24	59.27	FALSE	0	0
2026-08-21	14	1.45	PUT	0	5	70.45	FALSE	0	0
2026-08-21	15	1.7	PUT	0	6	62.34	FALSE	0	0
2026-08-21	16	2.7	PUT	0	11	53.29	TRUE	0	0
2026-08-21	17	3.3	PUT	0	28	52.8	TRUE	0	0
2026-08-21	18	4.14	PUT	0	6	64.92	TRUE	0	0
2026-08-21	19	4.7	PUT	0	1	59.93	TRUE	0	0
2026-08-21	20	4.6	PUT	0	1	61.72	TRUE	0	0
2026-08-21	21	6.8	PUT	0	1	54.79	TRUE	0	0
2026-08-21	22	0	PUT	0	0	49.84	TRUE	0	0
2026-08-21	23	0	PUT	0	0	51.47	TRUE	0	0
2026-08-21	24	9.4	PUT	0	7	55.19	TRUE	0	0
2026-08-21	25	0	PUT	0	0	0	TRUE	0	0
2026-08-21	26	0	PUT	0	0	0	TRUE	0	0
2026-08-21	27	0	PUT	0	0	0	TRUE	0	0
2026-08-21	30	0	PUT	0	0	0	TRUE	0	0
2027-01-15	3	11.92	CALL	0	33	135.42	TRUE	0	0
2027-01-15	5	10.77	CALL	0	12	97.83	TRUE	0	0
2027-01-15	8	9.72	CALL	0	19	74.03	TRUE	0	0
2027-01-15	10	6.1	CALL	0	434	65.64	TRUE	0	0
2027-01-15	13	4.9	CALL	0	122	60.71	TRUE	0	0
2027-01-15	15	3.5	CALL	0	909	65.2	TRUE	0	0
2027-01-15	17	2.87	CALL	31	597	61.26	FALSE	-0.13	-0.04
2027-01-15	20	2	CALL	17	1724	60.34	FALSE	-0.05	-0.02
2027-01-15	22	1.45	CALL	20	508	57.55	FALSE	1.45	0
2027-01-15	25	1.1	CALL	0	745	63.67	FALSE	0	0
2027-01-15	27	0.72	CALL	6	3493	55.6	FALSE	-0.03	-0.04
2027-01-15	30	0.6	CALL	0	571	77.61	FALSE	0	0
2027-01-15	32	0.55	CALL	0	22	108.03	FALSE	0	0
2027-01-15	35	0.5	CALL	0	167	113.66	FALSE	0	0
2027-01-15	37	0.3	CALL	0	4	117.06	FALSE	0	0
2027-01-15	3	0	PUT	0	0	420.92	FALSE	0	0
2027-01-15	5	0	PUT	0	5	393.59	FALSE	0	0
2027-01-15	8	0.48	PUT	0	96	116.65	FALSE	0	0
2027-01-15	10	1.21	PUT	0	45	122.52	FALSE	0	0
2027-01-15	13	2.22	PUT	0	1091	49.16	FALSE	0	0
2027-01-15	15	2.7	PUT	0	211	47.27	FALSE	0	0
2027-01-15	17	3.1	PUT	0	98	56.25	TRUE	0	0
2027-01-15	20	6	PUT	0	44	55.31	TRUE	0	0
2027-01-15	22	5.5	PUT	0	196	55.33	TRUE	0	0
2027-01-15	25	10.2	PUT	0	52	54.52	TRUE	0	0
2027-01-15	27	0	PUT	0	3	53.79	TRUE	0	0
2027-01-15	30	0	PUT	0	0	0	TRUE	0	0
2027-01-15	32	0	PUT	0	0	66.7	TRUE	0	0
2027-01-15	35	0	PUT	0	0	68.61	TRUE	0	0
2027-01-15	37	17.31	PUT	0	0	72.09	TRUE	0	0
2028-01-21	3	13	CALL	0	51	78.91	TRUE	0	0
2028-01-21	5	0	CALL	0	0	76.88	TRUE	0	0
2028-01-21	8	13.1	CALL	0	3	71.65	TRUE	0	0
2028-01-21	10	8	CALL	1	59	72.08	TRUE	8	0
2028-01-21	13	7	CALL	0	94	60.45	TRUE	0	0
2028-01-21	15	6.3	CALL	0	155	64.09	TRUE	0	0
2028-01-21	17	5.21	CALL	0	58	59.29	FALSE	0	0
2028-01-21	20	4.4	CALL	0	221	56.85	FALSE	0	0
2028-01-21	22	3.32	CALL	0	69	71.37	FALSE	0	0
2028-01-21	25	4	CALL	0	254	87.21	FALSE	0	0
2028-01-21	27	2.84	CALL	0	15	90.92	FALSE	0	0
2028-01-21	30	2.5	CALL	0	28	78.71	FALSE	0	0
2028-01-21	35	2.1	CALL	0	11	79.36	FALSE	0	0
2028-01-21	3	0	PUT	0	0	0	FALSE	0	0
2028-01-21	5	0	PUT	0	0	165.52	FALSE	0	0
2028-01-21	8	1.07	PUT	0	2	169.26	FALSE	0	0
2028-01-21	10	1.82	PUT	0	2	79.64	FALSE	0	0
2028-01-21	13	2.15	PUT	0	2	58.92	FALSE	0	0
2028-01-21	15	3.2	PUT	0	18	63.86	FALSE	0	0
2028-01-21	17	5.5	PUT	0	122	67.92	TRUE	0	0
2028-01-21	20	0	PUT	0	0	58.85	TRUE	0	0
2028-01-21	22	0	PUT	0	0	58.74	TRUE	0	0
2028-01-21	25	10.8	PUT	0	2	53.45	TRUE	0	0
2028-01-21	27	0	PUT	0	0	57.77	TRUE	0	0
2028-01-21	30	0	PUT	0	0	54.33	TRUE	0	0
2028-01-21	35	0	PUT	0	0	53.82	TRUE	0	0

Latest ADMA Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	38	$1.905
Jun 13, 2022 7:59 PM EST	100	$1.905
Jun 13, 2022 7:59 PM EST	100	$1.905
Jun 13, 2022 7:59 PM EST	36	$1.905
Jun 13, 2022 7:59 PM EST	100	$1.9

ADMA Biologics, Inc (ADMA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2019-10-09	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1368514/000000000019014431/0000000000-19-014431-index.htm
2020-02-07	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000083423720008032/0000834237-20-008032-index.htm
2020-03-09	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000083423720009209/0000834237-20-009209-index.htm
2019-05-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-03-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000091957419001192/0000919574-19-001192-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000091957420001141/0000919574-20-001141-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000108514619000734/0001085146-19-000734-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000108514620000752/0001085146-20-000752-index.htm
2019-06-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2019-06-07	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1368514/000112329219000869/0001123292-19-000869-index.htm
2020-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1368514/000114036120010160/0001140361-20-010160-index.htm
2020-04-29	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1368514/000114036120010161/0001140361-20-010161-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000119312519040961/0001193125-19-040961-index.htm
2019-05-23	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000119312519154707/0001193125-19-154707-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1368514/000119312520038101/0001193125-20-038101-index.htm
2018-10-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001175/0001193805-18-001175-index.htm
2018-10-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001198/0001193805-18-001198-index.htm
2018-10-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001210/0001193805-18-001210-index.htm
2018-10-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001238/0001193805-18-001238-index.htm
2018-11-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001316/0001193805-18-001316-index.htm
2018-11-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001319/0001193805-18-001319-index.htm
2018-12-19	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001425/0001193805-18-001425-index.htm
2018-12-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001429/0001193805-18-001429-index.htm
2018-12-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380518001431/0001193805-18-001431-index.htm
2019-01-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000012/0001193805-19-000012-index.htm
2019-01-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000026/0001193805-19-000026-index.htm
2019-01-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000090/0001193805-19-000090-index.htm
2019-01-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/0001193805-19-000091-index.htm
2019-01-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000092/0001193805-19-000092-index.htm
2019-01-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000098/0001193805-19-000098-index.htm
2019-02-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000160/0001193805-19-000160-index.htm
2019-02-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000246/0001193805-19-000246-index.htm
2019-02-27	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000251/0001193805-19-000251-index.htm
2019-03-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000254/0001193805-19-000254-index.htm
2019-03-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000280/0001193805-19-000280-index.htm
2019-03-13	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000281/0001193805-19-000281-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000292/0001193805-19-000292-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000293/0001193805-19-000293-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000294/0001193805-19-000294-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/0001193805-19-000295-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000296/0001193805-19-000296-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/0001193805-19-000297-index.htm
2019-03-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000301/0001193805-19-000301-index.htm
2019-04-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000332/0001193805-19-000332-index.htm
2019-04-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000339/0001193805-19-000339-index.htm
2019-04-05	PRE 14A	Other preliminary proxy statements	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000346/0001193805-19-000346-index.htm
2019-04-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000366/0001193805-19-000366-index.htm
2019-04-24	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000415/0001193805-19-000415-index.htm
2019-05-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000441/0001193805-19-000441-index.htm
2019-05-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000454/0001193805-19-000454-index.htm
2019-05-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000455/0001193805-19-000455-index.htm
2019-05-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000470/0001193805-19-000470-index.htm
2019-05-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000490/0001193805-19-000490-index.htm
2019-05-15	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000492/0001193805-19-000492-index.htm
2019-05-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000496/0001193805-19-000496-index.htm
2019-05-17	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000498/0001193805-19-000498-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000525/0001193805-19-000525-index.htm
2019-05-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000540/0001193805-19-000540-index.htm
2019-06-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000559/0001193805-19-000559-index.htm
2019-06-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000561/0001193805-19-000561-index.htm
2019-06-12	8-K/A	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000569/0001193805-19-000569-index.htm
2019-07-01	PRE 14A	Other preliminary proxy statements	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000614/0001193805-19-000614-index.htm
2019-07-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000621/0001193805-19-000621-index.htm
2019-07-16	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000637/0001193805-19-000637-index.htm
2019-08-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000714/0001193805-19-000714-index.htm
2019-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000715/0001193805-19-000715-index.htm
2019-08-22	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000761/0001193805-19-000761-index.htm
2019-08-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000774/0001193805-19-000774-index.htm
2019-09-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000798/0001193805-19-000798-index.htm
2019-09-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000839/0001193805-19-000839-index.htm
2019-10-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000887/0001193805-19-000887-index.htm
2019-10-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000893/0001193805-19-000893-index.htm
2019-10-04	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000903/0001193805-19-000903-index.htm
2019-10-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000905/0001193805-19-000905-index.htm
2019-10-07	424B7	Prospectus [Rule 424(b)(7)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000907/0001193805-19-000907-index.htm
2019-10-10	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001327/0001193805-19-001327-index.htm
2019-10-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001351/0001193805-19-001351-index.htm
2019-10-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001355/0001193805-19-001355-index.htm
2019-10-22	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001361/0001193805-19-001361-index.htm
2019-11-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001396/0001193805-19-001396-index.htm
2019-11-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001398/0001193805-19-001398-index.htm
2019-11-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001423/0001193805-19-001423-index.htm
2019-11-19	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001461/0001193805-19-001461-index.htm
2019-12-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380519001941/0001193805-19-001941-index.htm
2020-01-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000010/0001193805-20-000010-index.htm
2020-01-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000024/0001193805-20-000024-index.htm
2020-01-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000033/0001193805-20-000033-index.htm
2020-02-06	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000106/0001193805-20-000106-index.htm
2020-02-07	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000109/0001193805-20-000109-index.htm
2020-02-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000110/0001193805-20-000110-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000138/0001193805-20-000138-index.htm
2020-02-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000139/0001193805-20-000139-index.htm
2020-02-24	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000259/0001193805-20-000259-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-03-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-03-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000300/0001193805-20-000300-index.htm
2020-03-13	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000348/0001193805-20-000348-index.htm
2020-03-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000349/0001193805-20-000349-index.htm
2020-03-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000377/0001193805-20-000377-index.htm
2020-04-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000452/0001193805-20-000452-index.htm
2020-04-13	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000474/0001193805-20-000474-index.htm
2020-04-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000502/0001193805-20-000502-index.htm
2020-04-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000529/0001193805-20-000529-index.htm
2020-05-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000548/0001193805-20-000548-index.htm
2020-05-01	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000549/0001193805-20-000549-index.htm
2020-05-01	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/0001193805-20-000550-index.htm
2020-05-01	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000551/0001193805-20-000551-index.htm
2020-05-01	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/0001193805-20-000552-index.htm
2020-05-01	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000553/0001193805-20-000553-index.htm
2020-05-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000561/0001193805-20-000561-index.htm
2020-05-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000562/0001193805-20-000562-index.htm
2020-05-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000618/0001193805-20-000618-index.htm
2020-05-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000638/0001193805-20-000638-index.htm
2020-06-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000710/0001193805-20-000710-index.htm
2020-06-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000712/0001193805-20-000712-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2020-07-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000770/0001193805-20-000770-index.htm
2020-08-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000957/0001193805-20-000957-index.htm
2020-08-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000960/0001193805-20-000960-index.htm
2020-08-05	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000961/0001193805-20-000961-index.htm
2020-08-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-08-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-08-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-09-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001111/0001193805-20-001111-index.htm
2020-09-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2020-09-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-09-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-09-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2020-11-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001390/0001193805-20-001390-index.htm
2020-11-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001392/0001193805-20-001392-index.htm
2020-11-05	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001393/0001193805-20-001393-index.htm
2019-10-15	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1368514/999999999519002318/9999999995-19-002318-index.htm
2018-09-24	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1368514/999999999718008174/9999999997-18-008174-index.htm
2019-04-16	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1368514/999999999719002962/9999999997-19-002962-index.htm
2020-02-03	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1368514/999999999720000431/9999999997-20-000431-index.htm
2020-02-10	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1368514/999999999720000623/9999999997-20-000623-index.htm

ADMA Biologics, Inc (ADMA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ADMA Biologics, Inc (ADMA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 213%
Institutional Ownership: 5451%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2019-05-17	Jerrold B Grossman	Director	Buy	12,000.00	4.00	48,000.00	110,007.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-21	PERCEPTIVE ADVISORS LLC	10% Share Holder	Buy	4,000,000.00	4.00	16,000,000.00	11,521,102.00	https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-11	Jerrold B Grossman	Director	Buy	22,857.00	3.50	79,999.50	132,864.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-28	Jerrold B Grossman	Director	Buy	7,500.00			140,364.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-08-12	Jerrold B Grossman	Director	Buy	200.00	2.87	574.00	140,564.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12	Jerrold B Grossman	Director	Buy	5,000.00	2.89	14,450.00	145,564.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12	Jerrold B Grossman	Director	Buy	5,000.00	2.90	14,475.00	150,564.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-21	Jerrold B Grossman	Director	Buy	5,000.00	2.56	12,800.00	155,564.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-08-21	Jerrold B Grossman	Director	Buy	300.00	2.62	786.00	155,864.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-02-11	PERCEPTIVE ADVISORS LLC	10% Share Holder	Buy	4,563,700.00	3.50	15,972,950.00	16,084,802.00	https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-09-10	Jerrold B Grossman	Director	Buy	5,000.00	2.22	11,100.00	160,864.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-03-19	PERCEPTIVE ADVISORS LLC	10% Share Holder	Buy	500,000.00	2.10	1,050,000.00	16,584,802.00	https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2020-02-28	Adam S Grossman	President and CEO	Buy	100,000.00			166,098.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-08-10	Adam S Grossman	President and CEO	Buy	10.00	3.06	30.60	166,108.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10	Adam S Grossman	President and CEO	Buy	2,990.00	3.07	9,179.30	169,098.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10	Adam S Grossman	President and CEO	Buy	2,000.00	3.04	6,080.00	171,098.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-11	Adam S Grossman	President and CEO	Buy	1,000.00	2.97	2,970.00	172,098.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-09-08	Adam S Grossman	President and CEO	Buy	4,000.00	2.24	8,959.60	176,098.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2019-05-17	James Mond	EVP, CSO and CMO	Buy	4,500.00	4.00	18,000.00	17,889.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2020-08-13	MARTHA J DEMSKI	Director	Buy	2,000.00	2.88	5,760.00	2,000.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-02-11	James Mond	CSO and CMO	Buy	4,285.00	3.50	14,997.50	22,174.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-11	Jerrold B Grossman	Director	Buy	22,857.00	3.50	79,999.50	22,857.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2019-05-17	BRIAN LENZ	EVP, CFO	Buy	5,000.00	4.00	20,000.00	25,000.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2020-02-11	BRIAN LENZ	EVP, CFO	Buy	7,142.00	3.50	24,997.00	32,142.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2019-05-17	Adam S Grossman	President and CEO	Buy	5,000.00	4.00	20,000.00	37,527.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-09-11	MARTHA J DEMSKI	Director	Buy	2,200.00	2.29	5,038.00	4,200.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2019-06-06	Biotest Divestiture Trust	10% Share Holder	Sell	5,813,954.00	3.75	21,802,327.50	4,295,580.00	https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2020-02-28	ERIC I RICHMAN	Director	Buy	7,500.00			44,030.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2019-05-17	Lawrence P. Guiheen	Director	Buy	25,000.00	4.00	100,000.00	50,000.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2020-02-28	James Mond	EVP, CSO and CMO	Buy	40,000.00			62,174.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-02-11	Adam S Grossman	President and CEO	Buy	28,571.00	3.50	99,998.50	66,098.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-08-10	James Mond	EVP, CSO and CMO	Buy	5,000.00	2.88	14,400.00	67,174.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-10	James Mond	EVP, CSO and CMO	Buy	2,000.00	2.88	5,750.00	69,174.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-02-11	Lawrence P. Guiheen	Director	Buy	20,000.00	3.50	70,000.00	70,000.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-28	BRIAN LENZ	EVP, CFO	Buy	40,000.00			72,142.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-09-08	James Mond	EVP, CSO and CMO	Buy	4,000.00	2.20	8,800.00	73,174.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-02-28	Bryant Fong	Director	Buy	7,500.00			7,500.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-02-28	DOV A MD GOLDSTEIN	Director	Buy	7,500.00			7,500.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-02-28	STEVE ELMS	Director	Buy	7,500.00			7,500.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-08-11	BRIAN LENZ	EVP, CFO	Buy	4,000.00	2.97	11,860.00	76,142.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-02-28	Lawrence P. Guiheen	Director	Buy	7,500.00			77,500.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2019-05-17	Adam S Grossman	President and CEO	Buy	25,000.00	4.00	100,000.00	821,301.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-02-11	Adam S Grossman	President and CEO	Buy	57,143.00	3.50	200,000.50	878,444.00	https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm

ADMA Biologics, Inc

(NASDAQ:ADMA)